1. ScholarBank@NUS

Li Ann Andrea Wong

rp25177

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Li Ann Andrea Wong
Main Affiliation
 
Faculty
 
Email
csiawla@nus.edu.sg
 

Publications

Refined By:
Type:  Article
Subject:  Humans

Results 1-8 of 8 (Search time: 0.01 seconds).

Issue DateTitleAuthor(s)
124-Oct-2023CURATE.AI COR-Tx platform as a digital therapy and digital diagnostic for cognitive function in patients with brain tumour postradiotherapy treatment: Protocol for a prospective mixed-methods feasibility clinical trialRemus, A ; Tadeo, X ; Kai, GNS ; Blasiak, A ; Kee, T ; Vijayakumar, S ; Nguyen, L ; Raczkowska, MN ; Chai, QY; Aliyah, F; Rusalovski, Y; Teo, K; Yeo, TT; Wong, ALA ; Chia, D; Asplund, CL ; Ho, D ; Vellayappan, BA 
22018Dynamics of multiple resistance mechanisms in plasma DNA during EGFR-targeted therapies in non-small cell lung cancerTsui, D.W.Y; Murtaza, M; Wong, A.S.C ; Rueda, O.M; Smith, C.G; Chandrananda, D; Soo, R.A ; Lim, H.L; Goh, B.C ; Caldas, C; Forshew, T; Gale, D; Liu, W; Morris, J; Marass, F; Eisen, T; Chin, T.M ; Rosenfeld, N
31-Jan-2023FAM3C in circulating tumor-derived extracellular vesicles promotes non-small cell lung cancer growth in secondary sitesThuya, WL ; Kong, LR ; Syn, NL; Ding, LW ; Cheow, ESH ; Wong, RTX ; Wang, T ; Goh, RMWJ; Song, H ; Jayasinghe, MK; Le, MTN; Hu, JC; Yong, WP ; Lee, SC ; Wong, ALA ; Sethi, G ; Hung, HT ; Ho, PCL ; Thiery, JP ; Sze, SK ; Guo, T; Soo, RA ; Yang, H; Lim, YC ; Wang, L ; Goh, BC 
42016High expression of intratumoral stromal proteins is associated with chemotherapy resistance in breast cancerWang, T ; Srivastava, S ; Hartman, M ; Buhari, S.A ; Chan, C.-W ; Iau, P; Khin, L.W ; Wong, A ; Tan, S.-H ; Goh, B.-C ; Lee, S.-C 
52016Pharmacogenetics-Guided Phase i Study of Capecitabine on an Intermittent Schedule in Patients with Advanced or Metastatic Solid TumoursSoo, R.A ; Syn, N; Lee, S.-C; Wang, L; Lim, X.-Y; Loh, M; Tan, S.-H ; Zee, Y.-K; Wong, A.L.-A ; Chuah, B; Chan, D; Lim, S.-E; Goh, B.-C ; Soong, R ; Yong, W.-P 
61-Jun-2022Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast CancerLim, JSJ ; Wong, ALA ; Ow, SGW ; Ngoi, NYL ; Chan, GHJ; Ang, YLE; Chong, WQ; Lim, SE ; Lim, YW; Lee, M; Choo, JRE; Tan, HL; Yong, WP ; Soo, RA ; Tan, DSP ; Chee, CE ; Sundar, R ; Yadav, K ; Jain, S ; Wang, L ; Tai, BC ; Goh, BC ; Lee, SC 
72016Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancerWong A.L.A. ; Sundar R.; Wang T.-T. ; Ng T.-C. ; Zhang B. ; Tan S.-H. ; Soh T.I.P.; Pang A.S.L.; Tan C.-S.; Ow S.G.W.; Wang L. ; Mogro J.; Ho J.; Jeyasekharan A.D. ; Huang Y.; Thng C.-H. ; Chan C.-W. ; Hartman M. ; Iau P.; Buhari S.A. ; Goh B.-C. ; Lee S.-C. 
82018Pushing the limits of immune-related response: a case of “extreme pseudoprogression”Wong, A.S ; Thian, Y.-L ; Kapur, J ; Leong, C.-N ; Kee, P; Lee, C.-T; Lee, M.B